Effects of two monophasic oral contraceptives containing 150 mcg of desogestrel in combination with 20 or 30 mcg of ethinylestradiol on adolescent girls with oligomenorrhea and ovarian hyperandrogenism

Abstract

Adolescent girls in the early years after their first menstruation are characterized by frequent irregular menstrual cycles and absence of ovulation, often associated with clinical signs of hyperandrogenism, including hirsutism and acne. Often in these adolescent girls, both the ovarian structure and endocrine characteristics do not allow to distinguish the disease from polycystic ovarian syndrome (PCOS) observed in adults.

Keywords

contraceptive / desogestrel / ethinylestradiol / adolescent girls / oligomenorrhea / hyperandrogenism

References

[1] Apter D. (1980). Serum steroids and pituitary hormones in female: a partly longitudinal study. Clin.

[2] Endocrinol., 12, 107-20.

[3] Siegberg R., Nilsson C.G., Stenman U.K. and Widmola Q. (1986). Endocrinologie features of oligomenorrheic girls. Ferril. Sterill., 46, 852-6.

[4] Nappi C., Farace M.J., Minutolo M. Tomasseli A.P. and Montemgno U. (1987). Effect of a combination of ethynilestradiol in adolescens witholigomenorrhoea and ovarian hyperandrogenism. Eur. J. Obstet. Gynecoi. Reprod. Biol., 25, 209-19.

[5] Venturoli S., Porcu E., Fabbri R., Magrini O., Paradisi R., Palloti G., Gammi L. and Flamigni С. (1987). Postmenarchai evolution of endocrine pattern and ovarian aspects in adolscents with menstrual irregularities. Ferril. Sterill., 48, 78-85.

[6] Venturoli S., Porcu E., Paradisi R., Orsini L.F. and Flamigni C. (1984). Ovaries and menstrual cycles in adolescens. Gynecol. Obstet. Incest., 17, 219-22.

[7] Emans S.J., Grase E. and Golstein D.P. (1980). Oligomenorrea in adolescent girls. J.Pediatr., 97, 815-19.

[8] Baird D.T. (1976). Pituitary-ovarian relationships in disorders of menstruation. In: James V.H.T., Serio V. and Guisti G. (ed.). The Endicrine Function of the Human Ovary, h.349. (New York, Academic Press).

[9] Moll G.W. and Rosenfield R.L. (1983). Plasma free testosterone in the diagnosis of adolescents polycystic ovary syndrome. J. Pediatr., 102, 461-4.

[10] Venturoli S., Porcu E., Paradisi R., Flamingi C. (1981). Hyperandrogenism in postmenarchai oligomenorrhea: a stage of polycyclic ovary. Acta Endocrinol. (Copenh.), 97, (Suppl. 234), 72.

[11] Jung-Hoffmann C. and Kuhl H. (1987). Divergent effects of two low-dose oral contraceptives on sex hormon binding-globulin and free testosterone. Am. J. Obstet. Gynecol., 156, 199-203.

[12] Raj S.G., Raj M.H.G. Talbert L.M., Sloan C.S. and Hicks B. (1982). Normalization of testosterone levels using a low estrogen-containing oral contraceptive in women with policistic ovarian disease. Obstet. Gynecol., 60, 15-19.

[13] Seigberg R., Nillson C. G., Stenman U.H. and Whidholm O. (1984). Sex hormone profile in oligomennorrheic adolescent girls and the effect of oral contraceptive. Ferril Sterril., 41, 888-93.

[14] Ferriman D. and Gallwey J.D. (1961). Clinical assesment of body hair in women. J. Clin. Endocrinol. Metah., 21, 1440-7.

[15] Gohari P., Berkowits R.L. and Hobbins. J.C. (1987). Predictions of intrauterine growth retardation by determination total intrauterine. Am. J. Obstet. Gynecol., 127(3), 255-60.

[16] Nisula B.C., Loriaux D.L. and Wilson Y.A. (1978). Solid phase method for measurements of testotesterone-estradiol binding globulin in human serum. Steroids., 31 (5), 681-90.

[17] Zumoff B., Freeman R., Coupey S., Saenfdsc P., Markowitz M. and Kream J. (1983). Achronobiologic abnormality in LH secretion in teenage girls with polycystic ovary syndrome. N. Engl. J. Med., 309, 1206-9.

[18] Amirikia H., Savoy-Moore R.T., Sundareson F. S and Moghissi K. S. (1986). The effects of lond-term androgen treatment. Ferrill. Sterill., 45, 202-8.

[19] Derginr E.W., Hamburger A. D., De Jager E. and Van der Vies J. (1981). Binding of contraceptive progetogen ORG 2969 and its metabolites to receptor proteins and human SHBG. J. Steroid Biochem., 14, 175-83.

[20] Demis P., Newman M. and Anderson D.C. (1985). The treatment of hirsutism with a combination of desogestrel and ethinylestradiol. Clin. Endocrinol. (Ox.), 22, 29-36.

[21] Cullberg G. (1985). Low-dose desogestrel - ethinylestradiol combination jn hirsutism, androgen and sex hormone binding globulin in women with policectic ovary syndrome. Acta Obstet. Ginecol. Scand., 64, 195-202.

[22] Hammond G.L., Langley M.S., Robinson P.A. and Lund L. (1984). Serum steroid binding protein concentration, distribution of progetogens and bioavailability of testisteront during treatment with contraceptives containing or levonorgestrel. Ferril. Sterill., 42, 44-52.

[23] Rey-Stocker I., Zufferey M-M., Lemarchand M-T. and Rais M. (1980). Sensibilität der hypophyse der gonaden und der schiddruse beim jungen machen vol und nach kombinierten oralen kontrazeption. Gyndäkol. Rundsch., S, 135-61.

[24] Prader A. and Zachmann M. (1979). Treatment of excessively tall girls and boys with sex hormones. Pediatrics, 62, 1202-10.

RIGHTS & PERMISSIONS

Eсо-Vector